Pharmaceutical and Biological Products Contract Development and Manufacturing

Pharmaceutical and Biological Products Contract Development and Manufacturing
Product Description

Bora Pharmaceuticals is a full-service global CDMO specializing in the development and manufacturing of complex oral solid, liquid, semi-solid, ophthalmic, biologics, and sterile injectable pharmaceutical products for clinical and commercial supply. Our comprehensive solutions and expansive global network enable our clients to deliver much-needed therapies to patients worldwide. As a future focused CDMO, we know better than most that our own success is shaped by our partners victories. At Bora Pharmaceuticals, we see it as our mission, our duty, and our responsibility to make our mutual success more certain. 

Bora Pharmaceuticals

  • Country/Region:
    Canada
  • On CPHI since:
    2022
  • Employees:
    500 - 999
Company types
CMO/CDMO
Contract Service
Primary activities
Contract Manufacturer
Specifications
  • Details
    Oral Solid Dose
    Semi-Solids
    Liquids
    Nasal Spray
    Ophthalmic 
    Sterile Injectables
    Biologics

Bora Pharmaceuticals

  • Country/Region:
    Canada
  • On CPHI since:
    2022
  • Employees:
    500 - 999
Company types
CMO/CDMO
Contract Service
Primary activities
Contract Manufacturer

Bora Pharmaceuticals resources (1)

  • News CPHI Barcelona 2023: Tackling the Pharma Talent Precipice – Part 1

    This year at CPHI Barcelona (24–26 October, 2023) we sat down with C-suite executives and HR professionals to discuss the looming talent crisis in the pharmaceutical industry. With hybrid working persisting post-pandemic and a growing skills gap, how can the pharmaceutical supply chain adjust to a changing labour force?